| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/29/2014 | EP2418202B1 (4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors |
| 01/29/2014 | CN1849306B Matrix metalloproteinase inhibitors |
| 01/29/2014 | CN103539748A Method for preparing 5-(3,6-dihydro-2,6-dioxo-4-trifluoromethyl-1(2h)-pyrimidinyl)phenylthiol compounds |
| 01/29/2014 | CN103539747A Preparation method of 4,6-dichloropyrimidine |
| 01/29/2014 | CN103539702A Novel preparation method of N'-aryl-N, N-dimethyl formamidine |
| 01/29/2014 | CN102816114B Preparation method of HMG-CoA reductase inhibitor |
| 01/29/2014 | CN101501007B Quinazoline derivative |
| 01/28/2014 | US8637536 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2 |
| 01/28/2014 | US8637534 Fungicide active substance combinations |
| 01/28/2014 | US8637533 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/28/2014 | US8637532 Amino azaheterocyclic carboxamides |
| 01/28/2014 | US8637524 Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 |
| 01/28/2014 | US8637513 Heterocycle phenyl amide T-type calcium channel antagonists |
| 01/28/2014 | CA2808289C Process for the preparation of an intermediate useful in production of azoxystrobin |
| 01/28/2014 | CA2621040C 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/23/2014 | WO2014015054A1 Beta amino acid derivatives as integrin antagonists |
| 01/23/2014 | WO2014014310A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same |
| 01/23/2014 | US20140024666 Prolyl hydroxylase inhibitors |
| 01/23/2014 | US20140024665 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/23/2014 | US20140023642 1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof |
| 01/22/2014 | EP2686305A1 Quinazolinediones and their use |
| 01/22/2014 | CN103534241A Fak抑制剂 Fak inhibitors |
| 01/22/2014 | CN103534240A Selective FAK inhibitors |
| 01/22/2014 | CN103524433A Method for synthesizing gefitinib and intermediate thereof |
| 01/22/2014 | CN103524432A Method for preparing 2,3-dihydroquinazoline-4(3H)-ketone derivatives |
| 01/22/2014 | CN103524431A 3-benzyl-4-quinazolinone compound as well as synthetic method and applications thereof |
| 01/22/2014 | CN103524430A 4-(trans-4-substituted-3-butylene-1-alkynyl)-4-trifluoromethyl-3,4-dihydro substituted quinazoline-2(1H)-ketone compounds, and preparation method and application thereof |
| 01/22/2014 | CN103524429A Preparation method of ticagrelor and novel intermediates of ticagrelor |
| 01/22/2014 | CN103524428A Feather weight synthesis method of Fmoc-PNA-T-OH |
| 01/22/2014 | CN103524427A Preparation method as well as application of trimethoprem hapten |
| 01/22/2014 | CN103524426A Feather weight preparation method of cytosine containing PNA (pentose nucleic acid) monomer |
| 01/22/2014 | CN103524425A Crystal form V of ambrisentan as well as preparation method and application thereof |
| 01/22/2014 | CN103524424A Crystal form VI of ambrisentan as well as preparation method and application thereof |
| 01/22/2014 | CN103524423A Preparation method of 4,6-dichloropyrimidine-5-acetaldehyde |
| 01/22/2014 | CN102389409B TRP-P8 active compounds and therapeutic treatment methods |
| 01/22/2014 | CN102311392B Synthetic method of azoxystrobin and special intermediate for synthesis |
| 01/22/2014 | CN102167664B Fluorine-containing rare earth salt and applications thereof |
| 01/21/2014 | US8633211 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
| 01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
| 01/21/2014 | US8633209 Hydrobromide salts of a pyrazolylaminoquinazoline |
| 01/21/2014 | US8633208 6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands |
| 01/21/2014 | US8633207 Quinazoline compounds and methods of use thereof |
| 01/21/2014 | US8633186 Modulation of chemosensory receptors and ligands associated therewith |
| 01/21/2014 | US8633183 5-alkynyl-pyrimidines |
| 01/21/2014 | CA2600637C Tetrahydro- and dihydroquinazolinones |
| 01/16/2014 | WO2014011900A2 Inhibitors of the fibroblast growth factor receptor |
| 01/16/2014 | WO2014010748A1 Cyclopropane derivative having bace1 inhibiting activity |
| 01/16/2014 | WO2014010700A1 Amino compound, high-sensitivity mass spectrometry method for same, and method for assaying for biomarker |
| 01/16/2014 | WO2014009968A2 Process for rilpivirine using novel intermediate |
| 01/16/2014 | WO2014009872A1 Tetrahydroquinazolinone derivatives as parp inhibitors |
| 01/16/2014 | WO2014009318A1 3-{3-[1 -(4-dimethylaminomethyl-phenylamino)-1 -phenyl-meth-(z)-ylidene]-2-oxo-2,3-dihydro-1 h-indol-6-yll-propynoic acid ethylamide and its use in the treatment of cancer |
| 01/16/2014 | WO2014008636A1 Macrocyclic compounds as hiv integrase inhibitors |
| 01/16/2014 | WO2013177349A3 Quinazolinediones as tankyrase inhibitors |
| 01/16/2014 | WO2013163159A3 Design and synthesis of novel inhibitors of isoprenoid biosynthesis |
| 01/16/2014 | US20140018379 Pyrimidine derivatives |
| 01/16/2014 | US20140018378 Polymorphs of methyl (e)-2--3-methoxyacrylate |
| 01/16/2014 | US20140018376 Use of 1H-Quinazoline-2,4-Diones |
| 01/16/2014 | US20140018368 Hedgehog antagonists having zinc binding moieties |
| 01/16/2014 | US20140018363 2-aryl-4-quinazolinones and their pharmaceutical compositions |
| 01/16/2014 | US20140018326 Sulfonamides as hib protease inhibitors |
| 01/15/2014 | EP2684874A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors |
| 01/15/2014 | EP2683717A1 Preparation of 3-[2-[4-((6-fluoro-1, 2-benzisoxazol-3-yl)-l-piperidinyl)-6, 7, 8, 9-tetrahydro-9-hydroxy-2-methyl-4h-pyrido[ 1, 2-a]-pyrimidin-4-one (paliperidone) and paliperidone palmitate. |
| 01/15/2014 | EP2683694A1 Androgen receptor antagonists and uses thereof |
| 01/15/2014 | EP2683378A2 Amorphous form of lopinavir and ritonavir mixture |
| 01/15/2014 | CN103517897A Synthesis of cyclopentaquinazolines |
| 01/15/2014 | CN103508962A Preparation method of erlotinib hydrochloride form B |
| 01/15/2014 | CN103508961A Antitumor drug |
| 01/15/2014 | CN103508943A Compound taken as potassium channel regulator |
| 01/15/2014 | CN102382064B Quinnazolidone derivative, preparation method for same and application thereof |
| 01/14/2014 | US8629156 Tryptophan hydroxylase inhibitors |
| 01/14/2014 | US8629155 Aspartyl protease inhibitors |
| 01/14/2014 | US8629154 Substituted cycloalcano[e and d] pyrazolo [1,5-a]pyrimidines/antagonists of serotonin 5-HT6 receptors and methods for production and the use thereof |
| 01/14/2014 | US8628863 Indenopyrene compound and organic light-emitting device using the compound |
| 01/14/2014 | US8628789 Strong reversible hydrogels |
| 01/14/2014 | CA2623213C Piperazine derivatives as antimalarial agents |
| 01/09/2014 | WO2014006518A1 Compounds as inhibitor of dna double-strand break repair, methods and applications thereof |
| 01/09/2014 | WO2014006071A1 Indene derivatives, their preparation and use as medicaments |
| 01/09/2014 | US20140011997 Neprilysin inhibitors |
| 01/09/2014 | US20140011810 Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith |
| 01/09/2014 | US20140011803 Phenyl amino pyrimidine compounds and uses thereof |
| 01/09/2014 | CA2878346A1 New indene derivatives, their preparation and use as medicaments |
| 01/08/2014 | EP2682391A1 Indene derivatives, their preparation and use as medicaments |
| 01/08/2014 | EP2682389A1 Dihydropyrimidin-2(1H)-ones and dihydropyrimidin-2(1H)-thiones as inhibitors of sodium iodide symporter |
| 01/08/2014 | EP2680847A1 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof |
| 01/08/2014 | CN103497162A Synthetic method of 2-(4,6-dimethylpyrimidine-2-ylamidoformamidosulfonyl)methyl benzoate |
| 01/08/2014 | CN103497161A Process for preparing nicarbazin intermediate 4,6-dimethyl-2-hydroxypyrimidine through spray drying method |
| 01/08/2014 | CN102442954B Method for preparing 4,6-dihydroxy-pyrimidine from byproduct hydrocyanic acid of acrylonitrile |
| 01/08/2014 | CN102382102B Amide compound |
| 01/08/2014 | CN101541781B Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 01/07/2014 | US8623887 Compounds |
| 01/07/2014 | US8623884 Quinazolinedione derivatives as PARP inhibitors |
| 01/07/2014 | US8623883 4-phenylamino-quinazolin-6-yl-amides |
| 01/07/2014 | US8623872 Quinazolinone derivatives as PARP inhibitors |
| 01/07/2014 | US8623866 Nitrogen containing heteroaryl compounds |
| 01/07/2014 | US8623627 Labelling of fusion proteins with synthetic probes |
| 01/03/2014 | WO2014002105A1 Compounds for the treatment of dyslipidemia and other diseases |
| 01/03/2014 | WO2014001511A1 Preparation process of carboxylic acid derivatives and intermediates thereof |
| 01/03/2014 | CA2877326A1 Cyanoguanidines and their use as antiviral agents |
| 01/03/2014 | CA2875942A1 Preparation process of carboxylic acid derivatives and intermediates thereof |